SCHEMBL6703103

SCHEMBL6703103

NC(=O)N(c1ccc(Cl)cc1)c1cccc(N2C=Nc3occc3C2N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830844 0.75 TSHR (0.31) —
SCHEMBL4835390 0.74 KDM4E (0.36) —
SCHEMBL4831351 0.73 — —
SCHEMBL4833546 0.73 KDR (0.31) —
SCHEMBL4831187 0.71 MAPT (0.40) —
SCHEMBL6703099 0.69 NR3C2 (0.32) —
SCHEMBL4588620 0.67 HTR3E (0.47) —
SCHEMBL4830870 0.66 PGR (0.43) —
SCHEMBL4834430 0.66 RAB9A (0.47) —
SCHEMBL4830984 0.66 EPHX1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed
Send feedback